XNCR FY 2014 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$883M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-6.4% YoY

Gross Profit

-$9M-94.5% margin

Operating Income

-$16M-172.9% margin

Net Income

-$16M-172.5% margin

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$68M

Total Liabilities

$9M

Stockholders' Equity

$59M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$10M	-6.4%
Gross Profit	-$9M	-$7M	-31.8%
Operating Income	-$16M	-$11M	-56.4%
Net Income	-$16M	-$60M	+72.7%